COVID-19 Regulatory Special-Weekly Newsletter March 20, 2020 Biotech & Pharma by Mellalta Analyst Leave a Comment on COVID-19 Regulatory Special-Weekly Newsletter Read More
Perhaps anti-TFPI no longer a feasible strategy for Hemophilia-Novo Nordisk suspended three TFPI trials March 18, 2020 Biotech & Pharma, Business by Mellalta Analyst Leave a Comment on Perhaps anti-TFPI no longer a feasible strategy for Hemophilia-Novo Nordisk suspended three TFPI trials The discovery and characterization of the anticoagulant protein factor pathway inhibitor (TFPI) has led to the realization that inhibiting TFPI activity could restore functional hemostasis through the extrinsic pathway of blood clotting in a way […] Read More